| 1 |
Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004, 32 (3): 858-873.
|
| 2 |
Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med, 2008, 36 (1): 296-327.
|
| 3 |
Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 762-774.
|
| 4 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
|
| 5 |
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41 (2): 580-637.
|
| 6 |
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43 (3): 304-377.
|
| 7 |
Nandhabalan P, Ioannou N, Meadows C, et al. Refractory septic shock: our pragmatic approach[J]. Crit Care, 2018, 22 (1): 215.
|
| 8 |
Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update[J]. Crit Care Med, 2018, 46 (6): 997-1000.
|
| 9 |
Marik PE, Farkas JD. The changing paradigm of sepsis: early diagnosis, early antibiotics, early pressors, and early adjuvant treatment[J]. Crit Care Med, 2018, 46 (10): 1690-1692.
|
| 10 |
Vincent JL. How I treat septic shock[J]. Intensive Care Med, 2018, 44 (12): 2242-2244.
|
| 11 |
Kim WY, Jun JH, Huh JW, et al. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy[J]. Shock, 2013, 40 (6): 527-531.
|
| 12 |
Dorman T, Breslow MJ, Lipsett PA, et al. Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients[J]. Crit Care Med, 1998, 26 (10): 1646-1649.
|
| 13 |
Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock[J]. Intensive Care Med, 2018, 44 (1): 12-21.
|
| 14 |
Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock[J]. N Engl J Med, 2014, 370 (15): 1412-1421.
|
| 15 |
Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock[J]. N Engl J Med, 2018, 378 (9): 809-818.
|
| 16 |
Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock[J]. N Engl J Med, 2018, 378 (9): 797-808.
|
| 17 |
Fowler AA 3rd, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis[J]. J Transl Med, 2014 (12): 32.
|
| 18 |
Zabet MH, Mohammadi M, Ramezani M, et al. Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock[J]. J Res Pharm Pract, 2016, 5 (2): 94-100.
|
| 19 |
Donnino MW, Andersen LW, Chase M, et al. Rand-omized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study[J]. Crit Care Med, 2016, 44 (2): 360-367.
|
| 20 |
Marik PE, Khangoora V, Rivera R, et al. Hydrocorti-sone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study[J]. Chest, 2017, 151 (6): 1229-1238.
|
| 21 |
Joannes-Boyau O, Honoré PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial[J]. Intensive Care Med, 2013, 39 (9): 1535-1546.
|
| 22 |
Borthwick EM, Hill CJ, Rabindranath KS, et al. High-volume haemofiltration for sepsis in adults[J]. Cochrane Database Syst Rev, 2017, 1 (1): CD008075.
|
| 23 |
Vogel DJ, Murray J, Czapran AZ, et al. Veno-arterio-venous ECMO for septic cardiomyopathy: a single-centre experience[J]. Perfusion, 2018, 33 (1_suppl): 57-64.
|
| 24 |
Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: research priorities for sepsis and septic shock[J]. Intensive Care Med, 2018, 44 (9): 1400-1426.
|
| 25 |
Liu ZM, Chen J, Kou Q, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial[J]. Intensive Care Med, 2018, 44 (11): 1816-1825.
|
| 26 |
Deng M, Tang Y, Li W, et al. The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis[J]. Immunity, 2018, 49 (4): 740-753.e7.
|